Regeneron co-Chair, President and CSO George Yancopoulos discusses the company’s planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. (Source: Bloomberg)
Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline
Estimated read time
1 min read
You May Also Like
UK inflation unexpectedly slows to 2.5% in December
January 15, 2025
Jonathan Ruffer fails to beat cash after bet on US market crash
January 15, 2025
More From Author
Justin Verlander Called Out for Using Wife Kate Upton’s Name on Zoom
January 15, 2025
Wintermute Exec Calls for More DeFi Use Amid CeFi Concerns
January 15, 2025
+ There are no comments
Add yours